KR20170094903A - Composition containing complex extracts including Veratrum nigrum var. ussuriense, Juglans mandshurica, Rodgersia podophylla and Chaenomeles sinensis with antioxidant activity or whitening - Google Patents
Composition containing complex extracts including Veratrum nigrum var. ussuriense, Juglans mandshurica, Rodgersia podophylla and Chaenomeles sinensis with antioxidant activity or whitening Download PDFInfo
- Publication number
- KR20170094903A KR20170094903A KR1020160016208A KR20160016208A KR20170094903A KR 20170094903 A KR20170094903 A KR 20170094903A KR 1020160016208 A KR1020160016208 A KR 1020160016208A KR 20160016208 A KR20160016208 A KR 20160016208A KR 20170094903 A KR20170094903 A KR 20170094903A
- Authority
- KR
- South Korea
- Prior art keywords
- extract
- present
- spruce
- ussuriense
- skin
- Prior art date
Links
- 241000051708 Rodgersia podophylla Species 0.000 title claims abstract description 30
- 235000014075 Juglans mandschurica Nutrition 0.000 title claims abstract description 27
- 235000017831 Pseudocydonia sinensis Nutrition 0.000 title claims abstract description 26
- 241001507760 Chaenomeles sinensis Species 0.000 title claims abstract 5
- 241000305529 Juglans mandshurica Species 0.000 title claims abstract 5
- 239000000203 mixture Substances 0.000 title abstract description 71
- 230000003078 antioxidant effect Effects 0.000 title abstract description 32
- 230000002087 whitening effect Effects 0.000 title abstract description 29
- 239000000284 extract Substances 0.000 title description 134
- 241001176701 Veratrum nigrum var. ussuriense Species 0.000 title 1
- 239000004480 active ingredient Substances 0.000 claims abstract description 20
- 241000218657 Picea Species 0.000 claims description 77
- 102000003425 Tyrosinase Human genes 0.000 abstract description 40
- 108060008724 Tyrosinase Proteins 0.000 abstract description 40
- 230000000694 effects Effects 0.000 abstract description 36
- 235000013305 food Nutrition 0.000 abstract description 28
- 239000002537 cosmetic Substances 0.000 abstract description 22
- 230000002401 inhibitory effect Effects 0.000 abstract description 19
- 239000003963 antioxidant agent Substances 0.000 abstract description 15
- 230000002292 Radical scavenging effect Effects 0.000 abstract description 7
- 239000008194 pharmaceutical composition Substances 0.000 abstract description 7
- MGJZITXUQXWAKY-UHFFFAOYSA-N diphenyl-(2,4,6-trinitrophenyl)iminoazanium Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1N=[N+](C=1C=CC=CC=1)C1=CC=CC=C1 MGJZITXUQXWAKY-UHFFFAOYSA-N 0.000 abstract description 6
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 48
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 44
- 210000003491 skin Anatomy 0.000 description 34
- 230000000052 comparative effect Effects 0.000 description 29
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 24
- 235000017788 Cydonia oblonga Nutrition 0.000 description 23
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 22
- 244000264601 Juglans mandschurica Species 0.000 description 22
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 22
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 21
- 244000251905 Pseudocydonia sinensis Species 0.000 description 21
- 150000001875 compounds Chemical class 0.000 description 20
- 239000000049 pigment Substances 0.000 description 20
- 239000000523 sample Substances 0.000 description 20
- 239000002904 solvent Substances 0.000 description 19
- 238000000034 method Methods 0.000 description 18
- 238000002360 preparation method Methods 0.000 description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 16
- 238000000605 extraction Methods 0.000 description 15
- 235000006708 antioxidants Nutrition 0.000 description 14
- 230000032683 aging Effects 0.000 description 13
- 238000004519 manufacturing process Methods 0.000 description 13
- 239000000243 solution Substances 0.000 description 13
- 239000008363 phosphate buffer Substances 0.000 description 12
- 150000003254 radicals Chemical class 0.000 description 12
- 229960000271 arbutin Drugs 0.000 description 11
- 239000000796 flavoring agent Substances 0.000 description 11
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 11
- -1 superoxide radicals Chemical class 0.000 description 11
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 10
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 10
- 229930003268 Vitamin C Natural products 0.000 description 10
- 235000019154 vitamin C Nutrition 0.000 description 10
- 239000011718 vitamin C Substances 0.000 description 10
- 241000196324 Embryophyta Species 0.000 description 9
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 9
- 238000001035 drying Methods 0.000 description 9
- 235000013399 edible fruits Nutrition 0.000 description 9
- 238000009472 formulation Methods 0.000 description 9
- 210000004209 hair Anatomy 0.000 description 9
- 239000013641 positive control Substances 0.000 description 9
- 206010057190 Respiratory tract infections Diseases 0.000 description 8
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 8
- 239000003814 drug Substances 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- 239000007787 solid Substances 0.000 description 8
- 210000004027 cell Anatomy 0.000 description 7
- 239000003795 chemical substances by application Substances 0.000 description 7
- 201000010099 disease Diseases 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 229940079593 drug Drugs 0.000 description 7
- 238000001914 filtration Methods 0.000 description 7
- 235000013376 functional food Nutrition 0.000 description 7
- 230000002829 reductive effect Effects 0.000 description 7
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- 239000000654 additive Substances 0.000 description 6
- 235000013361 beverage Nutrition 0.000 description 6
- 235000019634 flavors Nutrition 0.000 description 6
- 230000006870 function Effects 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 6
- 239000000843 powder Substances 0.000 description 6
- 239000003642 reactive oxygen metabolite Substances 0.000 description 6
- 210000001519 tissue Anatomy 0.000 description 6
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 5
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 5
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 5
- 239000000839 emulsion Substances 0.000 description 5
- 239000000469 ethanolic extract Substances 0.000 description 5
- 235000013355 food flavoring agent Nutrition 0.000 description 5
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 5
- 238000002156 mixing Methods 0.000 description 5
- 230000003647 oxidation Effects 0.000 description 5
- 238000007254 oxidation reaction Methods 0.000 description 5
- 235000005875 quercetin Nutrition 0.000 description 5
- 229960001285 quercetin Drugs 0.000 description 5
- 230000009759 skin aging Effects 0.000 description 5
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 5
- 102000004190 Enzymes Human genes 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- WTDRDQBEARUVNC-UHFFFAOYSA-N L-Dopa Natural products OC(=O)C(N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-UHFFFAOYSA-N 0.000 description 4
- 241001505935 Phalaenopsis Species 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
- 230000000996 additive effect Effects 0.000 description 4
- 150000001298 alcohols Chemical class 0.000 description 4
- 239000003599 detergent Substances 0.000 description 4
- 239000003085 diluting agent Substances 0.000 description 4
- 239000003937 drug carrier Substances 0.000 description 4
- 239000003995 emulsifying agent Substances 0.000 description 4
- 235000003599 food sweetener Nutrition 0.000 description 4
- 230000007760 free radical scavenging Effects 0.000 description 4
- 239000000499 gel Substances 0.000 description 4
- 230000012010 growth Effects 0.000 description 4
- 230000005764 inhibitory process Effects 0.000 description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
- 230000008099 melanin synthesis Effects 0.000 description 4
- 210000002752 melanocyte Anatomy 0.000 description 4
- 239000000546 pharmaceutical excipient Substances 0.000 description 4
- 239000000419 plant extract Substances 0.000 description 4
- 239000003755 preservative agent Substances 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 230000037380 skin damage Effects 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- 239000003765 sweetening agent Substances 0.000 description 4
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 102000008186 Collagen Human genes 0.000 description 3
- 108010035532 Collagen Proteins 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- 235000013757 Juglans Nutrition 0.000 description 3
- 241000758789 Juglans Species 0.000 description 3
- WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 description 3
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 240000003296 Petasites japonicus Species 0.000 description 3
- 241000545593 Scolytinae Species 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 3
- 239000000969 carrier Substances 0.000 description 3
- 229920001436 collagen Polymers 0.000 description 3
- 239000006071 cream Substances 0.000 description 3
- 239000000287 crude extract Substances 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- XMOCLSLCDHWDHP-IUODEOHRSA-N epi-Gallocatechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@H]2O)=CC(O)=C(O)C(O)=C1 XMOCLSLCDHWDHP-IUODEOHRSA-N 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 238000005194 fractionation Methods 0.000 description 3
- 239000008187 granular material Substances 0.000 description 3
- 229940088597 hormone Drugs 0.000 description 3
- 239000005556 hormone Substances 0.000 description 3
- 230000001965 increasing effect Effects 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 239000008101 lactose Substances 0.000 description 3
- 239000006210 lotion Substances 0.000 description 3
- 229930014626 natural product Natural products 0.000 description 3
- 230000036542 oxidative stress Effects 0.000 description 3
- 239000003381 stabilizer Substances 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 2
- 241000208340 Araliaceae Species 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 241001164374 Calyx Species 0.000 description 2
- 241001507936 Chaenomeles Species 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 241000254173 Coleoptera Species 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- AHMIDUVKSGCHAU-UHFFFAOYSA-N Dopaquinone Natural products OC(=O)C(N)CC1=CC(=O)C(=O)C=C1 AHMIDUVKSGCHAU-UHFFFAOYSA-N 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- 229930191978 Gibberellin Natural products 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- XMOCLSLCDHWDHP-UHFFFAOYSA-N L-Epigallocatechin Natural products OC1CC2=C(O)C=C(O)C=C2OC1C1=CC(O)=C(O)C(O)=C1 XMOCLSLCDHWDHP-UHFFFAOYSA-N 0.000 description 2
- AHMIDUVKSGCHAU-LURJTMIESA-N L-dopaquinone Chemical compound [O-]C(=O)[C@@H]([NH3+])CC1=CC(=O)C(=O)C=C1 AHMIDUVKSGCHAU-LURJTMIESA-N 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 2
- 239000004909 Moisturizer Substances 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 2
- 235000003140 Panax quinquefolius Nutrition 0.000 description 2
- 208000012641 Pigmentation disease Diseases 0.000 description 2
- 244000184734 Pyrus japonica Species 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- 241000208292 Solanaceae Species 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 2
- 235000013334 alcoholic beverage Nutrition 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- 235000010323 ascorbic acid Nutrition 0.000 description 2
- 239000011668 ascorbic acid Substances 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- 231100000504 carcinogenesis Toxicity 0.000 description 2
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 2
- 235000005487 catechin Nutrition 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 238000004132 cross linking Methods 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- DZYNKLUGCOSVKS-UHFFFAOYSA-N epigallocatechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3cc(O)c(O)c(O)c3 DZYNKLUGCOSVKS-UHFFFAOYSA-N 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 239000000945 filler Substances 0.000 description 2
- 235000013373 food additive Nutrition 0.000 description 2
- 239000002778 food additive Substances 0.000 description 2
- IXORZMNAPKEEDV-UHFFFAOYSA-N gibberellic acid GA3 Natural products OC(=O)C1C2(C3)CC(=C)C3(O)CCC2C2(C=CC3O)C1C3(C)C(=O)O2 IXORZMNAPKEEDV-UHFFFAOYSA-N 0.000 description 2
- 239000003448 gibberellin Substances 0.000 description 2
- 235000008434 ginseng Nutrition 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 239000000314 lubricant Substances 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 235000001055 magnesium Nutrition 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 2
- 239000008108 microcrystalline cellulose Substances 0.000 description 2
- 229940016286 microcrystalline cellulose Drugs 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 239000012046 mixed solvent Substances 0.000 description 2
- 230000001333 moisturizer Effects 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 239000006072 paste Substances 0.000 description 2
- 235000011007 phosphoric acid Nutrition 0.000 description 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 239000012488 sample solution Substances 0.000 description 2
- 235000015067 sauces Nutrition 0.000 description 2
- 229920002545 silicone oil Polymers 0.000 description 2
- 210000004927 skin cell Anatomy 0.000 description 2
- 239000000344 soap Substances 0.000 description 2
- 239000012064 sodium phosphate buffer Substances 0.000 description 2
- 239000002689 soil Substances 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 229940032147 starch Drugs 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 230000000475 sunscreen effect Effects 0.000 description 2
- 239000000516 sunscreening agent Substances 0.000 description 2
- 239000000829 suppository Substances 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 229960001295 tocopherol Drugs 0.000 description 2
- 235000010384 tocopherol Nutrition 0.000 description 2
- 229930003799 tocopherol Natural products 0.000 description 2
- 239000011732 tocopherol Substances 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- 239000002023 wood Substances 0.000 description 2
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 2
- XMOCLSLCDHWDHP-SWLSCSKDSA-N (+)-Epigallocatechin Natural products C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC(O)=C(O)C(O)=C1 XMOCLSLCDHWDHP-SWLSCSKDSA-N 0.000 description 1
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- PFTAWBLQPZVEMU-ZFWWWQNUSA-N (+)-epicatechin Natural products C1([C@@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-ZFWWWQNUSA-N 0.000 description 1
- PFTAWBLQPZVEMU-UKRRQHHQSA-N (-)-epicatechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-UKRRQHHQSA-N 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- 206010069754 Acquired gene mutation Diseases 0.000 description 1
- 244000144927 Aloe barbadensis Species 0.000 description 1
- 235000002961 Aloe barbadensis Nutrition 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 1
- 235000017491 Bambusa tulda Nutrition 0.000 description 1
- 241000255789 Bombyx mori Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 235000002568 Capsicum frutescens Nutrition 0.000 description 1
- 240000008574 Capsicum frutescens Species 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 208000005623 Carcinogenesis Diseases 0.000 description 1
- 235000014036 Castanea Nutrition 0.000 description 1
- 241001070941 Castanea Species 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 235000007516 Chrysanthemum Nutrition 0.000 description 1
- 240000005250 Chrysanthemum indicum Species 0.000 description 1
- 244000223760 Cinnamomum zeylanicum Species 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 241001503991 Consolida Species 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 241000238424 Crustacea Species 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- 230000009946 DNA mutation Effects 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- 206010014970 Ephelides Diseases 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- 102000016359 Fibronectins Human genes 0.000 description 1
- 108010067306 Fibronectins Proteins 0.000 description 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 1
- 240000009088 Fragaria x ananassa Species 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 235000010254 Jasminum officinale Nutrition 0.000 description 1
- 240000005385 Jasminum sambac Species 0.000 description 1
- 240000007472 Leucaena leucocephala Species 0.000 description 1
- 235000010643 Leucaena leucocephala Nutrition 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 244000070406 Malus silvestris Species 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 1
- 208000000112 Myalgia Diseases 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 235000002789 Panax ginseng Nutrition 0.000 description 1
- 244000220503 Persea thunbergii Species 0.000 description 1
- 201000005702 Pertussis Diseases 0.000 description 1
- 241001508789 Phalaenopsis sp. Species 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 244000082204 Phyllostachys viridis Species 0.000 description 1
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 1
- 240000009188 Phyllostachys vivax Species 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 241000206609 Porphyra Species 0.000 description 1
- 241000206619 Porphyra sp. Species 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- 102000016611 Proteoglycans Human genes 0.000 description 1
- 108010067787 Proteoglycans Proteins 0.000 description 1
- 235000011158 Prunus mume Nutrition 0.000 description 1
- 244000018795 Prunus mume Species 0.000 description 1
- 240000005809 Prunus persica Species 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- 241001507762 Pseudocydonia Species 0.000 description 1
- 241000589774 Pseudomonas sp. Species 0.000 description 1
- 241000221662 Sclerotinia Species 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 208000000453 Skin Neoplasms Diseases 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 239000004283 Sodium sorbate Substances 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 241000256248 Spodoptera Species 0.000 description 1
- 241000256247 Spodoptera exigua Species 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- 241000001727 Tropicoporus linteus Species 0.000 description 1
- 241001170744 Veratrum nigrum Species 0.000 description 1
- 241000219094 Vitaceae Species 0.000 description 1
- MECHNRXZTMCUDQ-UHFFFAOYSA-N Vitamin D2 Natural products C1CCC2(C)C(C(C)C=CC(C)C(C)C)CCC2C1=CC=C1CC(O)CCC1=C MECHNRXZTMCUDQ-UHFFFAOYSA-N 0.000 description 1
- 206010047642 Vitiligo Diseases 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- PSUBPFRWJHQJIA-UHFFFAOYSA-K [Ca+2].C(C=CC=CC)(=O)[O-].[Na+].C(C=CC=CC)(=O)[O-].C(C=CC=CC)(=O)[O-] Chemical compound [Ca+2].C(C=CC=CC)(=O)[O-].[Na+].C(C=CC=CC)(=O)[O-].C(C=CC=CC)(=O)[O-] PSUBPFRWJHQJIA-UHFFFAOYSA-K 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 235000011054 acetic acid Nutrition 0.000 description 1
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000002535 acidifier Substances 0.000 description 1
- 229940095602 acidifiers Drugs 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000001361 adipic acid Substances 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 235000011399 aloe vera Nutrition 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 235000021016 apples Nutrition 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 235000008452 baby food Nutrition 0.000 description 1
- 239000011425 bamboo Substances 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 235000013527 bean curd Nutrition 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 230000008033 biological extinction Effects 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 239000004067 bulking agent Substances 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 235000001465 calcium Nutrition 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 239000004301 calcium benzoate Substances 0.000 description 1
- 235000010237 calcium benzoate Nutrition 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 239000000378 calcium silicate Substances 0.000 description 1
- 229910052918 calcium silicate Inorganic materials 0.000 description 1
- 235000012241 calcium silicate Nutrition 0.000 description 1
- HZQXCUSDXIKLGS-UHFFFAOYSA-L calcium;dibenzoate;trihydrate Chemical compound O.O.O.[Ca+2].[O-]C(=O)C1=CC=CC=C1.[O-]C(=O)C1=CC=CC=C1 HZQXCUSDXIKLGS-UHFFFAOYSA-L 0.000 description 1
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 1
- 230000036952 cancer formation Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 150000001765 catechin Chemical class 0.000 description 1
- 230000005779 cell damage Effects 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 235000012721 chromium Nutrition 0.000 description 1
- 229950001002 cianidanol Drugs 0.000 description 1
- 235000017803 cinnamon Nutrition 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- 235000013495 cobalt Nutrition 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 239000010779 crude oil Substances 0.000 description 1
- 235000015140 cultured milk Nutrition 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- MHUWZNTUIIFHAS-CLFAGFIQSA-N dioleoyl phosphatidic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(COP(O)(O)=O)OC(=O)CCCCCCC\C=C/CCCCCCCC MHUWZNTUIIFHAS-CLFAGFIQSA-N 0.000 description 1
- 238000002845 discoloration Methods 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 231100000673 dose–response relationship Toxicity 0.000 description 1
- 239000006196 drop Substances 0.000 description 1
- 229940126534 drug product Drugs 0.000 description 1
- 238000007908 dry granulation Methods 0.000 description 1
- 210000005069 ears Anatomy 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- LPTRNLNOHUVQMS-UHFFFAOYSA-N epicatechin Natural products Cc1cc(O)cc2OC(C(O)Cc12)c1ccc(O)c(O)c1 LPTRNLNOHUVQMS-UHFFFAOYSA-N 0.000 description 1
- 235000012734 epicatechin Nutrition 0.000 description 1
- 229960002061 ergocalciferol Drugs 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 210000001508 eye Anatomy 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 235000013332 fish product Nutrition 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 235000011087 fumaric acid Nutrition 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 229910052732 germanium Inorganic materials 0.000 description 1
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 description 1
- IXORZMNAPKEEDV-OBDJNFEBSA-N gibberellin A3 Chemical compound C([C@@]1(O)C(=C)C[C@@]2(C1)[C@H]1C(O)=O)C[C@H]2[C@]2(C=C[C@@H]3O)[C@H]1[C@]3(C)C(=O)O2 IXORZMNAPKEEDV-OBDJNFEBSA-N 0.000 description 1
- 235000020710 ginseng extract Nutrition 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 235000021021 grapes Nutrition 0.000 description 1
- 235000009569 green tea Nutrition 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 210000001144 hymen Anatomy 0.000 description 1
- 210000002865 immune cell Anatomy 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 230000037451 immune surveillance Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 239000007928 intraperitoneal injection Substances 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- 235000021109 kimchi Nutrition 0.000 description 1
- 229960001375 lactose Drugs 0.000 description 1
- 229960004502 levodopa Drugs 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 235000014666 liquid concentrate Nutrition 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 229960001855 mannitol Drugs 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 235000013622 meat product Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 210000002780 melanosome Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 238000006241 metabolic reaction Methods 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 229910052750 molybdenum Inorganic materials 0.000 description 1
- 239000011733 molybdenum Substances 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 235000021096 natural sweeteners Nutrition 0.000 description 1
- 208000004296 neuralgia Diseases 0.000 description 1
- 210000000440 neutrophil Anatomy 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000012454 non-polar solvent Substances 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 231100000956 nontoxicity Toxicity 0.000 description 1
- 235000012149 noodles Nutrition 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- 239000006201 parenteral dosage form Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 238000004161 plant tissue culture Methods 0.000 description 1
- 208000008423 pleurisy Diseases 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 239000004300 potassium benzoate Substances 0.000 description 1
- 235000010235 potassium benzoate Nutrition 0.000 description 1
- 229940103091 potassium benzoate Drugs 0.000 description 1
- 239000004302 potassium sorbate Substances 0.000 description 1
- 235000010241 potassium sorbate Nutrition 0.000 description 1
- 229940069338 potassium sorbate Drugs 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000003244 pro-oxidative effect Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 1
- 229960003415 propylparaben Drugs 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000012264 purified product Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 235000021067 refined food Nutrition 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 235000020944 retinol Nutrition 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 239000011607 retinol Substances 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 230000009758 senescence Effects 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 201000000849 skin cancer Diseases 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 235000011888 snacks Nutrition 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 229960003885 sodium benzoate Drugs 0.000 description 1
- LROWVYNUWKVTCU-STWYSWDKSA-M sodium sorbate Chemical compound [Na+].C\C=C\C=C\C([O-])=O LROWVYNUWKVTCU-STWYSWDKSA-M 0.000 description 1
- 235000019250 sodium sorbate Nutrition 0.000 description 1
- 230000037439 somatic mutation Effects 0.000 description 1
- 239000004071 soot Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 235000013555 soy sauce Nutrition 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 235000021012 strawberries Nutrition 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 235000012222 talc Nutrition 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 239000000606 toothpaste Substances 0.000 description 1
- 229940034610 toothpaste Drugs 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 239000006211 transdermal dosage form Substances 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 238000002137 ultrasound extraction Methods 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 238000005292 vacuum distillation Methods 0.000 description 1
- 238000003828 vacuum filtration Methods 0.000 description 1
- 229910052720 vanadium Inorganic materials 0.000 description 1
- GPPXJZIENCGNKB-UHFFFAOYSA-N vanadium Chemical compound [V]#[V] GPPXJZIENCGNKB-UHFFFAOYSA-N 0.000 description 1
- 239000003981 vehicle Substances 0.000 description 1
- MECHNRXZTMCUDQ-RKHKHRCZSA-N vitamin D2 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)/C=C/[C@H](C)C(C)C)=C\C=C1\C[C@@H](O)CCC1=C MECHNRXZTMCUDQ-RKHKHRCZSA-N 0.000 description 1
- 235000001892 vitamin D2 Nutrition 0.000 description 1
- 239000011653 vitamin D2 Substances 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
- 238000005550 wet granulation Methods 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/52—Juglandaceae (Walnut family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/732—Chaenomeles, e.g. flowering quince
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/318—Foods, ingredients or supplements having a functional effect on health having an effect on skin health and hair or coat
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Mycology (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Botany (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Dermatology (AREA)
- Birds (AREA)
- Medicines Containing Plant Substances (AREA)
- Cosmetics (AREA)
Abstract
The present invention relates to the use of V eratrum There is nigrum . ussuriense , Juglans mandshurica , Rodgersia Podophylla , and Chaenomeles Sinensis , or a fraction thereof, as an active ingredient. The present invention also relates to a cosmetic composition, a food composition, an external composition for external use, a composition for external application for skin, and a pharmaceutical composition.
The compositions of the present invention are excellent in DPPH radical scavenging activity, excellent in efficiency of inhibiting tyrosinase activity, and can be used for antioxidant or whitening purposes.
Description
The present invention relates to the use of V eratrum There is nigrum . ussuriense ), spruce ( Juglans mandshurica , Rodgersia podophylla , and Chaenomeles Sinensis ) or fractions thereof as an active ingredient, to a cosmetic composition for antioxidant or whitening, a food composition, a quasi-drug composition, a composition for external application for skin, and a pharmaceutical composition.
All organisms, including humans, experience life and aging, two biological changes throughout their lives. Growth refers to an increase in the size or function of an individual, while aging refers to a phenomenon in which the size or function of an individual decreases or declines, and growth and aging can occur at the same time. However, aging phenomenon becomes more prominent with increasing time and age, and cell division ability and metabolic activity gradually decrease, so that the organism can not become ill or perform physical and functional smooth activities. The mechanism of senescence is divided into genetic program theory, somatic mutation theory, error fracture theory, free radical theory, endocrine theory by specific hormone action, immune disruption due to impaired immune surveillance, stress theory, lipofuscin and lipid peroxidation There are various aging related theories such as accumulation of wastes based on the accumulation of collagen, and crosslinking (binding) following the progress of crosslinking of tissue collagen fibers, but there is no clear explanation yet.
Among the various aging phenomena such as decline of hearing, smell, taste, reduction of lung capacity, weight loss of organs, aging phenomenon, which is generally felt and felt most directly by people, is the skin aging phenomenon. The most supported theory about the aging phenomenon occurring in the skin tissue is the free radical theory. According to the theory, free radicals are generated in the living body by metabolic reaction, ultraviolet ray, soot and environmental hormone, and this free radical As the barrier is destroyed, lipids, proteins, polysaccharides and nucleic acids, which are the main constituents of skin, are oxidized and consequently promote the aging process of skin cells and tissues. In other words, skin is oxidatively stressed by radicals such as superoxide radicals (O 2- ) and hydroxyl radicals (OH) and non-radicals such as hydrogen peroxide (H 2 O 2 ) . In particular, when proteins are oxidized, collagen, hyaluronic acid, elastin, proteoglycan, fibronectin, etc., which are the connective tissues of the skin, are severed, resulting in severe hyperinflammation reaction and decreased skin elasticity If this becomes worse, DNA mutation leads to mutation, cancer induction, and immune function deterioration. Therefore, in order to prevent skin aging, it is necessary to prevent skin damage by eliminating free radicals caused by various causes, and already damaged cells need to be regenerated and reproduced by active metabolism.
On the other hand, human skin color largely depends on the amount of melanin pigment contained in skin cells. People with a lot of melanin pigments have brown or black skin, while those with very low melanin pigment cause vitiligo. Melanin pigment is produced from tyrosine by tyrosinase in pigmented cell called melanocyte which exists in basal membrane of skin. Melanin pigment protects skin from excessive ultraviolet rays, so it plays an important role in suppressing skin damage and skin cancer caused by ducts. However, when melanin is excessively produced by daylight, hormone changes, inflammation, medicines, etc., the pigment of the skin is deposited, which causes cosmetic problems. For example, skin pigmentation of the skin is caused by an increase in the amount of melanin pigment, which means that the production of melanin pigment is promoted or the number of melanocytes is increased.
Accordingly, in recent years, various whitening cosmetics and medicines for preventing and improving such problems have been developed and marketed. Currently, in the development of a whitening agent for skin cosmetics, a method of decolorizing the resulting melanin pigment and a method of inhibiting the activity of tyrosinase, an enzyme that forms a melanin pigment, are known. However, it is known that the whitening agent using tocopherol or the like, which is used for reducing the melanin pigment, has little discoloration effect on the melanin pigment. Accordingly, inhibitors that inhibit the activity of tyrosinase and inhibit the production of melanin pigment have been attracting attention.
Tyrosinase is an enzyme that catalyzes the oxidation of monophenols and is contained in the melanocytes of higher animals. Tyrosine is oxidized by this enzyme and melanin pigment is produced through a series of chemical reactions and oxidation. This melanin pigment is brown or black, which absorbs excess light in vivo, which adversely affects skin beauty. In view of the fact that the activity of tyrosinase is inhibited, the production of melanin pigment can be inhibited. Thus, in the field of the conventional cosmetics, natural plant extracts and the like are used as inhibitors of tyrosinase activity as natural whitening extracts.
Under these circumstances, the inventors of the present invention have made efforts to develop a plant extract that has superior radical scavenging ability and can effectively inhibit tyrosinase activity, as compared with the conventional plant extract. As a result of intensive efforts, the inventors of the present invention have found that a combination of spruce, It was confirmed that the extract had an excellent radical scavenging ability and could effectively inhibit tyrosinase activity, thus completing the present invention.
One object of the present invention is to provide a method of < RTI ID = 0.0 > There is nigrum . ussuriense ), spruce ( Juglans mandshurica), imp debt (Rodgersia Podophylla ), and quince trees ( Chaenomeles Sinensis ) or a fraction thereof as an active ingredient.
Another object of the present invention is to provide There is nigrum . ussuriense ), spruce ( Juglans mandshurica), imp debt (Rodgersia Podophylla ), and quince trees ( Chaenomeles Sinensis ) or a fraction thereof as an active ingredient.
Another object of the present invention is to provide a device There is nigrum . ussuriense ), spruce ( Juglans mandshurica), imp debt (Rodgersia Podophylla ), and quince trees ( Chaenomeles Sinensis ) or a fraction thereof as an active ingredient.
Another object of the present invention is to provide a device There is nigrum . ussuriense ), spruce ( Juglans mandshurica), imp debt (Rodgersia Podophylla ), and quince trees ( Chaenomeles Sinensis ) or a fraction thereof as an active ingredient.
Another object of the present invention is to provide a device There is nigrum . ussuriense , Juglans mandshurica , Rodgersia Podophylla , and Chaenomeles Sinensis , or a fraction thereof, as an active ingredient.
Hereinafter, the present invention will be described in more detail.
In order to achieve the above object, the present invention In some embodiments, a participation (V eratrum There is nigrum . ussuriense , Juglans mandshurica , Rodgersia Podophylla ), and quince trees ( Chaenomeles Sinensis ) or a fraction thereof as an active ingredient.
The cosmetic composition of the present invention as an active ingredient, with the participation (V eratrum There is nigrum . ussuriense , Juglans mandshurica , Rodgersia podophylla , and Chaenomeles sinensis .
The above roads are native to the northern part of Korea and north of Gyeongsangbuk-do, and are distributed in Russia and China. A perennial plant called scientific name, also known as a big journey, Wang journey that grows under the trees on the mountain is Veratrum nigrum , and more specifically V eratrum There is nigrum . It is ussuriense . The stem is 1-1.5cm high, and the old leaves are covered with net-shaped fibers at the bottom, the rootstock is short, and the stem of beard is thick. The leaf is in the lower part of the trunk, and the leaf at the bottom is wide oval, 40cm long, 10cm wide, pointed at the end, narrowed downward to connect to the sheath, wrapped around the stem, Lt; / RTI > Flowers bloom in July-September, 6 pieces of crustacean, with long oval shape and blunt ends. On the back of the outer sculpture, there is a dense white hairs. The flower is 1cm in diameter, dark purple, 6 stamens, about 1/2 of the length of the hymen, and the stigma divides into 3 pieces. The ovary is ovate and hairy on the lower part, and the style is divided into three branches and tilted backward. The fruit is a three-angular oval-shaped capillary, purple, about 1 cm in length, and spreads in three branches.
In the present invention, the cosmetic composition of the present invention can be applied to an extract obtained by drying and crushing a participating pathway into powder, and it can contain leaves, stems, stem barks, branches, bark, roots, Specifically, it may be a leaf, a stem, a stem shell, a branch, a bark, a flower, or all of them, which corresponds to the ground part of the participant except the root.
The spiny tree is also known as 楸 子 木 (楸 子 木), and the fruit is called 楸 子 (楸 子), the scientific name is Juglans It is mandshurica . It grows on the sides of the mountain and is about 20cm high. The bark is dark gray and bursts vertically. Leaves are odd numbered compound leaf, small leaves are 7 ~ 17 pieces. Long elliptical or oval oval, 7 ~ 28cm long, 10cm wide. There is a sawtooth, the front side has fine hairs but gradually disappears, and the back side has hairy or no hairs. Flower is bloomed in April as monogenous flower. Male flower is bloomed from the side branch of last year of 10 ~ 25cm with new leaf in May ~ June, and the female flower ear is 6 ~ 13cm long and extends straight from the end of branch , 7 to 10 flowers per ears. Fruit is a nucleus, 4 ~ 8cm long, egg-shaped or elliptical, ripened in September-October. The yellowish green fine hairs are dense, the ends are pointed, and are very hard. Seeds contain a large amount of fat, 55.5 ~ 60.6% fat, rich in nutrients, and unsaturated fatty acids in fat. Seed is used as a medicine to prevent arteriosclerosis. It is a deciduous broad-leaved arboreous tree native to the northwestern part of Korea, such as Sobaeksan and Mt. Soki. It is also distributed in northern China, northeast and Siberia in the former Soviet Union.
In the present invention, the cosmetic composition of the present invention can be applied to extraction by drying and crushing the spruce tree, and may be applied to an extract, and may include leaves, stem, stem skin, branches, bark, roots, And may specifically include leaves, stems, stem barks, branches, bark, flowers or all of them corresponding to the underside of the spruce tree except for the roots, and more specifically, leaves and stems may be used from above .
The above-mentioned gecko debt is also known as a mountain, a sum, a wagon, and the scientific name is Rodgersia Podophylla . I am a perennial herb in the deep mountain shore in the north of the central part. The growth environment is a lot of valley water, the humidity is high and the soil is fertile and grows out of sunlight. Its height is about 1cm. Leaves are alternate phyllotaxis and petiole is long and split into 3 ~ 6 pieces. Small leaves come out of five, large ones are about 50cm in diameter, and the upper ones have 1 to 4 small leaves. The small leaf has irregular sawtooth on the edge in the shape of inverted egg. There are hairs on upper petiole and back petiole. The flower blooms in June, and it is yellowish white. The length of the peduncle is 20 ~ 40cm. There are 10 stamens, longer than calyxes, and 2 stigma. The fruit runs in broad egg shape around August to October, and there are no petals. The calyx is deeply divided into 5 pieces, and the piece is long ovate and white. The rootstock is large and thick. It is distributed in Gyeongsangbuk-do, Gangwon-do, Pyongan, North Hamgyong, North Hamgyong, and Japan.
In the present invention, the cosmetic composition of the present invention can be applied to an extract obtained by drying and crushing a bark beetle with powder, and it can contain leaves, stems, stem barks, branches, bark, roots, flowers or both of them. Specifically, leaves, stems, stem peels, branches, bark, flowers, or all of them corresponding to the underside of the bugle fan except the root.
The quince tree is a tree of Chinese origin, and is widely planted in the central and southern regions. Its scientific name is Chaenomeles Sinensis . The soil is deep and drainage is good and likes the fertile place. They are planted for ornamental, fruit or bonsai. The bark is purple-brown and shiny. The bark of the old tree blooms in the spring and falls, and the place of the bark is bluish. The height reaches 10m. There are hairs on young branches and there is a dark brownish shine of two years. Leaves are alternate phyllotaxis ovate or long oval. There is a sawtooth on the upper edge of the leaf, a line on the bottom, and the cotyledon drops early. The flower has five rounded petals. In May, one flower blooms at the end of the twig. It is light red with a diameter of 2.5 ~ 3cm. The petal is shaped like an inverted egg and the tip is concave. Fruits are oval or inverted egg, 10 ~ 20cm in length, 8 ~ 15cm in diameter, and woody is developed. It ripens in yellow in September and has a good aroma but strong acidity. It is used as a medicinal material for the food of fruit and contains a large amount of tannin. Jinhae, geomdan, governor, and pain relief. Applicable diseases include pertussis, asthma, bronchitis, pneumonia, pleuritis, diarrhea, neuralgia, myalgia and anemia.
In the present invention, the cosmetic composition of the present invention can be applied to an extract obtained by drying and crushing a quince tree and pulverizing the quince tree. The cosmetic composition may contain leaves, stem, stem skin, branch, And may specifically include a leaf, a stem, a stem skin, a branch, a bark, a flower or all of them corresponding to a ground part of a quince tree except for a root. More specifically, a stem may be used from above.
In the present invention, the term "above ground" means a portion of the upper surface of the earth about the earth in the plant. That is, it refers to the upper surface of the ground excluding roots, which includes leaves, stems, stem barks, branches, bark, flowers, or all of them except roots.
The term "complex extract" in the present invention refers to a form of an extract obtained by mixing natural products such as plants, followed by extraction with one or more solvents, or a mixture of extracts obtained by extracting each natural product with a solvent. In the present invention, the compound extract may be a mixture of extracts of Solanaceae, Spodoptera, Bombyx mori, Leucocephalus and Sclerotinia with an extractive solvent, have.
The term "extract" in the present invention refers to an extract obtained by extracting the extract itself, such as an extract obtained by extraction, a diluted or concentrated solution of the extract, a dried product obtained by drying the extract, a controlled preparation or purified product of the extracted solution, , ≪ / RTI > The extract of the present invention can be extracted from natural, hybrid, or mutant plants of the respective plants, and can also be extracted from plant tissue cultures.
In the extraction of the present invention, the extraction method is not particularly limited, and extraction can be carried out according to a method commonly used in the art. Non-limiting examples of the extraction method include hydrothermal extraction, ultrasonic extraction, filtration, and reflux extraction. These may be performed alone or in combination with two or more methods.
Drying of the extract in the present invention can be carried out by a known method insofar as the useful components from the collected plants are not destroyed, and can be carried out, for example, by a natural drying method in shade. In addition, the crushing can be sufficient to break up the crushed to such an extent that the useful components of the plant can be sufficiently extracted in the subsequent extraction process, and can be pulverized. The drying and crushing steps may be carried out in reverse order or repeatedly as required.
To participate in the present invention (V eratrum There is nigrum . ussuriense ), spruce ( Juglans mandshurica , Rodgersia podophylla , and Chaenomeles The type of extraction solvent used to extract Sinensis is not particularly limited and any solvent known in the art can be used. In the present invention, the complex extract may be obtained by extracting with water, a C 1 to C 4 lower alcohol or a mixed solvent thereof. Further, non-limiting examples of the extraction solvent include water; C 1 to C 4 lower alcohols such as methanol, ethanol, propyl alcohol and butyl alcohol; Polyhydric alcohols such as glycerin, butylene glycol and propylene glycol; And hydrocarbon solvents such as methyl acetate, ethyl acetate, acetone, benzene, hexane, diethyl ether, and dichloromethane; Or a mixture thereof. Specifically, water, a lower alcohol, 1,3-butylene glycol, and ethyl acetate may be used alone or in admixture of two or more.
To participate in the present invention (V eratrum There is nigrum . ussuriense , Juglans mandshurica , Rodgersia Podophylla ), and quince trees ( Chaenomeles Sinensis ), more specifically, water, ethanol, methanol can be used. Using the above solvent, V eratrum There is nigrum . ussuriense ), spruce ( Juglans mandshurica), imp debt (Rodgersia Podophylla , and Chaenomeles Sinensis , followed by one or more extractions to prepare a complex solvent extract. The dry extract obtained by vacuum distillation of the solvent extract, followed by lyophilization or spray drying can be prepared have. In a specific example of the present invention, water and ethanol were used as extracting solvents to prepare a combined extract of Phellinus linteus, Spodoptera exigua, .
The extraction can be carried out by extracting a mixture (complex) obtained by mixing the plant dry matter, There is nigrum . ussuriense ), spruce ( Juglans mandshurica , Rodgersia podophylla , and Chaenomeles Sinensis ) can be prepared by extracting a mixed sample (mixture) containing the active ingredient at a weight ratio of 1.5 to 2.5: 1.5 to 2.5: 0.5 to 1.5: 0.5 to 1.5, and specifically 1.8 to 2.2: 1.8 to 2.2 : 0.8 to 1.2: 0.8 to 1.2 in weight ratio. In this case, it is possible to produce a complex extract (mixture) containing the extract of the present invention which has antioxidative and whitening activity at the same time as that of a single extract, Can be obtained.
The extraction is carried out at a temperature of from 10 to 80 ° C, specifically from 15 to 50 ° C, using a solvent having a volume of from 1 to 10 times by volume, specifically from 1 to 5 times, To 30 days, more specifically, 12 hours to 18 days. The process of extracting the crude extracts in a liquid phase one to five consecutive times, including the above-mentioned dried and crushed products, . ≪ / RTI >
In order to remove suspended solid particles, the complex extracts extracted in the present invention may be filtered by filtration using, for example, nylon, filter paper, etc., or filtered using freeze filtration or the like, It can be dried and used.
The liquid crude extract may be separated from the dry matter of the plant by vacuum filtration or the like, followed by concentration or drying. For example, the liquid crude extract may be concentrated in a vacuum rotary condenser at 20 to 100 ° C, preferably 40 to 70 ° C, and the liquid extract may be dried to obtain a powdered complex extract have. The concentrated or powdered complex extract may be used in water, alcohol, dimethyl sulfoxide (DMSO), or a mixed solvent thereof, if necessary.
In an embodiment of the present invention, 1 kg of a completely mixed sample, which is a mixed sample of 2: 2: 1: 1, is mixed with 9 liters of ethanol and 15 At 37 ° C for 14 days, followed by filtration and concentration under reduced pressure to obtain a dried complex extract (Example 2).
The term "fraction " as used herein means a product obtained by performing fractionation to separate a specific component or a specific component group from a mixture containing various components.
The fractionation method for obtaining the fraction in the present invention is not particularly limited and may be carried out according to a method commonly used in the art. Non-limiting examples of such fractionation methods include, but are not limited to,eratrum nigrum there is. ussuriense), Spruce (Juglans mandshuricaHowever,Rodgersia Podophylla), And quince treesChaenomeles Sinensis) Is extracted and the obtained complex extract is treated with a predetermined solvent to obtain fractions from the extract.
The kind of the solvent used for obtaining the fraction in the present invention is not particularly limited, and any solvent known in the art can be used. Non-limiting examples of the fraction solvent include polar solvents such as water and alcohol; And non-polar solvents such as hexane, ethyl acetate, chloroform, and dichloromethane. These may be used alone or in combination of two or more. When alcohol is used in the fraction solvent, C 1 to C 4 alcohols can be specifically used.
The term "antioxidant" used in the present invention means an antioxidant action. The human body has a balance between a prooxidant and an antioxidant, but due to various factors, Becomes unbalanced and tilting toward oxidation promotes oxidative stress leading to potential cellular damage and pathological disease. Reactive oxygen species (ROS), which is a direct cause of oxidative stress, is unstable and highly reactive. It reacts easily with various bio-materials, attacks irreversible damage to cells and tissues, Cytotoxicity and carcinogenesis. Active nitrogen species (RNS) such as NO, HNO 2 , and ONOO - are produced by the immune response of macrophage neutrophils and other immune cells during inflammatory reaction, and ROS is also produced. Such active oxygen oxidizes and destroys cells in the body, thereby exposing them to various diseases. In addition, the antioxidant has a function of inhibiting oxidation of cells due to highly reactive free radicals or reactive oxygen species (ROS) according to oxidative stress caused by intracellular metabolism or ultraviolet rays And eliminating free radicals or reactive oxygen species, thereby reducing damage to the cells.
To participate in an embodiment of the present invention (V eratrum There is nigrum . ussuriense ), spruce ( Juglans mandshurica), imp debt (Rodgersia Podophylla ), and quince trees ( Chaenomeles The concentration of the IC 50 (concentration of the sample which scavenges 50% of the DPPH free radical) of the ethanol extract of Sinensis was 11.4 / / ml, which was similar to that of the positive control vitamin C known to have high antioxidant activity. Antioxidant activity was excellent. In addition, it was confirmed that DPPH free radical scavenging ability was remarkably superior to vitamin C, which is a positive control group, at 100 μg / ml and 20 μg / ml of the combined extract, and as a result, the combined extract of spruce, It has been confirmed that it has excellent antioxidative activity through inhibition of free radical which accelerates the skin aging process. Accordingly, it was confirmed that the compound extract of the present invention can be applied to cosmetic compositions for antioxidation. In addition, as a part of the present invention, the combined extracts of the spruce tree, the spruce tree, and the spruce tree include the extracts of the spruce tree, the spruce tree, the extract of the spruce tree, the extract of the spruce tree, Compared with the complex extract of the goby drapery, it has an excellent antioxidative activity by inhibiting free radicals promoting the aging process of the skin, and exhibits an effect of remarkably lowering the degree of aging process and skin damage by antioxidant activity (Experimental Example 1).
As used herein, the term "whitening" refers to a method of increasing the lightness of skin with reduced brightness due to excessive pigment such as melanin or keeping the brightness of skin at a certain level, Skin, and the like. Specifically, it may mean skin whitening. For the purpose of the present invention, the whitening is carried out by means of inhibiting tyrosinase activity, which promotes the synthesis of melanin formed in the skin by the ethanol combined extract of spruce, spruce, But is not limited to.
Melanin is a pigment that is widely distributed in living organisms such as skin, hair and eyes. Melanin is synthesized in Melanosome in Melanocyte of human skin. Tyrosine (tyrosine) Melanin is biosynthesized by the oxidation and polymerization reaction which is converted to DOPA (3,4-dihydroxy-phenylalanine) or DOPA quinone (Dopaquinone) as a starting material. Biosynthesized melanin increases resistance to skin irritation such as ultraviolet rays, but since excessive melanin synthesis causes pigmentation such as spots, freckles, and black spots, tyrosinase activity measurement is regarded as an important indicator of skin whitening effect have.
In one embodiment of the present invention, the IC 50 (concentration of a sample inhibiting 50% inhibition of tyrosinase activity) of the combined extract of P. vivax, P. forest, The amount of tyrosinase was significantly lower than that of arbutin, and the ability to inhibit the activity of tyrosinase was 5 times higher than that of arbutin. In addition, it was confirmed that tyrosinase activity was significantly lower in the positive control group than arbutin at the concentrations of 100 μg / ml and 20 μg / ml in the combined extracts of P. thunbergii, P. japonicus, It was confirmed that tyrosinase activity was significantly lower than that of arbutin at a concentration of 20 占 퐂 / ml and remarkably high efficiency of inhibiting tyrosinase activity was observed.
In addition, as a result of participation of the present invention, the combined extracts of the spruce tree, the spruce tree, and the spruce tree can be used as extracts of the spruce tree, Compared with the complex extract, the tyrosinase activity, which plays a key role in the melanin biosynthesis process, is suppressed to a remarkably high level, thereby effectively inhibiting the production of melanin pigment, thereby preventing skin aging and whitening effect (Experimental Example 2). That is, the complex extract of the present invention has an excellent inhibitory activity on the activity of tyrosinase, effectively inhibiting the production of melanin, and can be applied to a cosmetic composition for whitening.
In addition, it was confirmed that the combined extracts of spruce, decanter, and quercetin could be applied simultaneously for antioxidative and whitening purposes (Examples 1 and 2)
In the present invention, the cosmetic composition may be prepared in various forms, for example, emulsion, lotion, cream (oil-in-water type, oil-in-water type, multiphase), solution, suspension (anhydrous and aqueous) , A gel, a mask, a pack or a powder, and the like. The cosmetic composition of the present invention may contain an acceptable carrier in cosmetic formulations in addition to its effective ingredient. As used herein, the term " acceptable carrier for a cosmetic preparation "refers to a compound or composition that is already known and used in the cosmetic preparation, or a compound or composition to be developed in the future, and which has no toxicity such that the human body can be adapted to contact with skin. The carrier may comprise from about 1% to about 99.99% by weight, specifically from about 50% to about 99% by weight of the composition, based on the total weight of the composition.
However, since the ratio depends on the above-mentioned formulation of the cosmetic composition and its specific application site (face or hands) or its preferable application amount, the ratio is limited in any aspect to the scope of the present invention It should not be.
Examples of the carrier include alcohols, oils, surfactants, fatty acids, silicone oils, humectants, moisturizers, viscosifiers, emulsifiers, stabilizers, sunscreens, coloring agents and perfumes. The compounds / compositions which can be used as the carrier and which can be used as alcohols, oils, surfactants, fatty acids, silicone oils, wetting agents, moisturizers, viscosifiers, emulsions, stabilizers, sunscreens, A person skilled in the art can select and use appropriate substances / compositions.
Specifically, the cosmetic composition can be manufactured to have a formulation selected from a solution suspension, an emulsion, a gel, a cream, a lotion, a powder, a soap, a cleansing, a body wash, a cleansing and a spray, although the formulation is not limited.
The invention in another aspect, a participating (V eratrum There is nigrum . ussuriense , Juglans mandshurica , Rodgersia Podophylla ), and quince trees ( Chaenomeles Sinensis ) or a fraction thereof as an active ingredient.
In the present invention, the engagement (V eratrum There is nigrum . ussuriense ), spruce ( Juglans mandshurica , Rodgersia podophylla , and Chaenomeles Sinensis ), complex extracts, fractions, antioxidants and whitening are as described above.
The food composition of the present invention may comprise an acceptable food-aid additive and may further comprise suitable carriers, excipients and diluents conventionally used in the manufacture of food.
In the present invention, the term " food " means a natural product or a processed product containing one or more nutrients. Specifically, the term " food " means that the food can be directly eaten through a certain degree of processing. Functional foods, beverages, food additives, and beverage additives. Examples of the food include various foods, beverages, gums, tea, vitamin complex, and functional foods. In addition, the food of the present invention may contain special nutritional foods (eg, crude oil, spirit, infant food, etc.), meat products, fish products, tofu, jelly, noodles (eg, (Such as soy sauce, soybean paste, hot pepper paste, mixed sauce), sauces, confectionery (eg snacks), dairy products (eg fermented milk, cheese), other processed foods, kimchi, pickled foods But are not limited to, natural flavors (eg, ramen soup, etc.), vitamin complexes, alcoholic beverages, alcoholic beverages and other health supplement foods. The functional food, beverage, food additive or beverage additive may be produced by a conventional production method.
The term "functional food" as used herein refers to a food group that is imparted with added value to function or express the function of the food by physical, biochemical, biotechnological techniques, etc., or to control the biological defense rhythm of the food composition, Means a food which has been designed and processed so as to sufficiently express the body's control function with respect to the living body. Specifically, it may be a health functional food. In particular, the composition of the present invention is suitable for application as a food composition for antioxidant or whitening. The functional food may include a food-acceptable food-aid additive, and may further comprise suitable carriers, excipients and diluents conventionally used in the production of functional foods.
In the food composition, the amount of the complex extract may be 0.00001 wt% or more, specifically 0.1 wt% or more, and 80 wt% or less, specifically 50 wt% or less, more specifically 40 wt% or less , And when the food is a beverage, it is contained in a proportion of not less than 0.001 g, specifically not less than 0.01 g, not more than 50 g, specifically not more than 10 g, more specifically not more than 2 g based on 100 ml of the total volume of the food But is not limited thereto.
The food composition of the present invention may contain sweetening agents, flavoring agents, physiologically active ingredients, minerals and the like in addition to the active ingredients thereof. Sweetening agents may be used in an amount that sweetens the food in a suitable manner, and may be natural or synthetic. Specific examples of natural sweeteners include corn syrup solids, sugar sweeteners such as honey, sucrose, fructose, lactose and maltose. Flavors may be used to enhance taste or flavor, both natural and synthetic. Specifically, a natural one is used. When using natural ones, the purpose of nutritional fortification can be performed in addition to the flavor. Examples of natural flavoring agents include those obtained from apples, lemons, citrus fruits, grapes, strawberries, peaches, and the like, or those obtained from green tea leaves, Asiatica, Daegu, Cinnamon, Chrysanthemum leaves and Jasmine. Also, those obtained from ginseng (red ginseng), bamboo shoots, aloe vera, banks and the like can be used. The natural flavoring agent may be a liquid concentrate or a solid form of extract. Synthetic flavors may be used depending on the case, and synthetic flavors such as esters, alcohols, aldehydes, terpenes and the like may be used. Examples of the physiologically active substance include catechins such as catechin, epicatechin, gallocatechin and epigallocatechin, and vitamins such as retinol, ascorbic acid, tocopherol, calciferol, thiamine and riboflavin. As the mineral, calcium, magnesium, chromium, cobalt, copper, fluoride, germanium, iodine, iron, lithium, magnesium, manganese, molybdenum, phosphorus, potassium, selenium, silicon, sodium, sulfur, vanadium and zinc can be used.
In addition, the food composition of the present invention may contain preservatives, emulsifiers, acidifiers, thickeners and the like in addition to the above sweeteners.
Such preservatives, emulsifiers and the like are preferably added in a very small amount as long as they can attain an application to which they are added. The term " trace amount " means, when expressed numerically, in the range of 0.0005% by weight to about 0.5% by weight based on the total weight of the food composition. Examples of the preservative which can be used include calcium sodium sorbate, sodium sorbate, potassium sorbate, calcium benzoate, sodium benzoate, potassium benzoate and EDTA (ethylenediaminetetraacetic acid). Examples of the emulsifier which can be used include acacia gum, carboxymethyl cellulose, xanthan gum, pectin and the like. Examples of the acidulant that can be used include acid, malic acid, fumaric acid, adipic acid, phosphoric acid, gluconic acid, tartaric acid, ascorbic acid, acetic acid, and phosphoric acid. Such an acidulant may be added so that the food composition has a proper acidity for the purpose of inhibiting the growth of microorganisms other than the purpose of enhancing the taste. Agents that may be used include suspending agents, sedimentation agents, gel formers, bulking agents and the like.
In another aspect, the present invention relates to a method of inhibiting < RTI ID = 0.0 > There is nigrum . ussuriense , Juglans mandshurica , Rodgersia Podophylla ), and quince trees ( Chaenomeles Sinensis ) or a fraction thereof as an active ingredient.
In the present invention, the engagement (V eratrum There is nigrum . ussuriense ), spruce ( Juglans mandshurica , Rodgersia podophylla , and Chaenomeles Sinensis ), complex extracts, fractions, antioxidants and whitening are as described above.
The term "quasi-drug product" used in the present invention means products that are less active than drugs, among the products used for diagnosing, treating, improving, alleviating, treating or preventing diseases of human or animal. For example, Quasi-drugs are products that are used for the purpose of treating or preventing diseases of humans or animals, products that are mild or have no direct action on the human body.
The quasi-drug composition of the present invention can be used as a body cleanser, a disinfectant cleaner, a detergent, a kitchen detergent, a cleaning detergent, a toothpaste, a gauze agent, a wet tissue, a detergent, a soap, a hand wash, a hair cleanser, a hair softener, a humidifier filler, But the present invention is not limited thereto.
In another aspect, the present invention relates to a method of inhibiting < RTI ID = 0.0 > There is nigrum . ussuriense ), spruce ( Juglans mandshurica , Rodgersia podophylla , and Chaenomeles Sinensis ) or a fraction thereof as an active ingredient.
In the present invention, the engagement (V eratrum There is nigrum . ussuriense ), spruce ( Juglans mandshurica , Rodgersia podophylla , and Chaenomeles Sinensis ), complex extracts, fractions, antioxidants and whitening are as described above.
The term "external preparation" of the present invention is a preparation for external use, and includes external preparation, external preparation, external solution, ointment, warning agent, suppository, etc. The external preparation for skin of the present invention, .
The external preparation for skin according to the present invention may be a parenteral dosage form which is formulated in solid, semi-solid or liquid form by adding a compatible inorganic or organic carrier, excipient and diluent. The preparation for parenteral administration may be a transdermal dosage form selected from the group consisting of drops, ointments, lotions, gels, creams, patches, sprays, suspensions, and emulsions.
Examples of the carrier, excipient and diluent which can be contained in the external preparation include lactose, dextrose, sucrose, oligosaccharide, sorbitol, mannitol, xylitol, erythritol, maltitol, starch, acacia rubber, alginate, gelatin, calcium phosphate, calcium silicate, Cellulose, methylcellulose, microcrystalline cellulose, polyvinylpyrrolidone, water, methylhydroxybenzoate, propylhydroxybenzoate, talc, magnesium stearate and mineral oil.
The composition for external application for skin according to each formulation may be mixed with other ingredients other than the complex extract of the present invention without any difficulties by those skilled in the art depending on the formulation or use purpose of other external preparations for skin or the like. Effect can occur.
The composition for external application for skin of the present invention may contain 0.0001 to 30% (w / v) of the combined extract of the total composition by weight. If it is contained at less than 0.0001% (w / v), the antioxidant, whitening effect of the skin can not be substantially expected. On the other hand, if it exceeds 30% (w / v), the overall processability of the composition such as solubility in a solvent may be lowered and its use for various purposes such as formulations may be restricted.
In another aspect, the present invention relates to a method of inhibiting < RTI ID = 0.0 > There is nigrum . ussuriense , Juglans mandshurica , Rodgersia Podophylla ), and quince trees ( Chaenomeles Sinensis ) or a fraction thereof as an active ingredient.
In the present invention,eratrum nigrum there is. ussuriense), Spruce (Juglans mandshuricaHowever,Rodgersia Podophylla), And quince treesChaenomeles Sinensis), Complex extract, fraction, antioxidant and whitening are as described above.
In the present invention, the pharmaceutical composition may comprise a pharmaceutically acceptable carrier or an additive. In the present invention, the expression "pharmaceutically acceptable" means that the application (subject) does not have the above-mentioned toxicity that is adaptable without inhibiting the activity of the active ingredient. The "carrier" is defined as a compound that facilitates the addition of a compound into a cell or tissue.
The extracts of the present invention may be administered alone or in admixture with any convenient carrier, etc., and such dosage forms may be single-dose or repeated-dose formulations. The pharmaceutical composition containing the extract may be a solid preparation or a liquid preparation. Solid preparations include, but are not limited to, powders, granules, tablets, capsules, suppositories, and the like. Solid form preparations may include, but are not limited to, carriers, flavoring agents, binders, preservatives, disintegrants, lubricants, fillers, and the like. Examples of the liquid preparation include water, a solution such as a solution of propylene glycol, a suspension, an emulsion, and the like, but not limited thereto, and it can be prepared by adding a suitable coloring agent, a flavoring agent, a stabilizer, a tackifying agent and the like. For example, powders can be prepared by simple mixing of an extract, which is an effective ingredient of the present invention, with a suitable pharmaceutically acceptable carrier such as lactose, starch, microcrystalline cellulose and the like. The granule is the above-mentioned extract of the present invention; A suitable pharmaceutically acceptable carrier; And a suitable pharmaceutically acceptable binder such as polyvinylpyrrolidone and hydroxypropylcellulose, followed by wet granulation using a solvent such as water, ethanol, or isopropanol, or dry granulation using a compressive force . Tablets may also be prepared by mixing the granules with a suitable pharmaceutically acceptable lubricant such as magnesium stearate and then tableting using a tableting machine.
The extract of the present invention may be administered orally or parenterally depending on the disease to be treated and the condition of the subject, an injection (for example, intramuscular injection, intraperitoneal injection, intravenous injection, infusion, subcutaneous injection, implant) Rectal, rectal, transdermal, topical, and the like, but the present invention is not limited thereto. May be formulated into suitable dosage unit formulations, including those conventionally used and non-toxic, pharmaceutically acceptable carriers, additives, vehicles according to the route of administration.
The pharmaceutical composition of the present invention may be administered at a daily dose of from about 0.0001 mg / kg to about 10 g / kg, and from about 0.001 mg / kg to about 1 g / kg. However, the dosage may vary depending on the degree of purification of the mixture, the condition of the patient (age, sex, weight, etc.), severity of the condition being treated, and the like. For convenience, the total daily dose may be administered in divided doses several times a day as needed.
When the composition of the present invention is used as a pharmaceutical composition, the content of the complex extract in the composition can be appropriately adjusted to an effective amount capable of exhibiting anti-inflammatory activity according to the symptoms of the disease, the progress of the symptoms, May be 0.0001% by weight or more, specifically 0.001% by weight or more, and 80% by weight or less, and more specifically, 50% by weight or less based on the total weight of the composition.
The composition of the present invention may be used as a < RTI ID = 0.0 > There is nigrum . ussuriense ), spruce ( Juglans mandshurica), imp fan (Rodgersia Podophylla), and pseudocydonia (Chaenomeles Sinensis) combined extract or comprising a fraction as an effective component thereof, and the antioxidant activity and the whitening effect is excellent, a cosmetic composition for antioxidant or whitening, food compositions, quasi-drugs of Composition for skin external application, and pharmaceutical composition.
FIG. 1 is a graph showing DPPH radical scavenging activity of a combined extract of spruce, decanter, and quercetin with participation of the present invention.
FIG. 2 shows the results of evaluation of tyrosinase activity of a combination extract of spruce, decoy, and quercetin with participation of the present invention.
Hereinafter, embodiments of the present invention will be described in detail so that those skilled in the art can easily carry out the present invention. The present invention may, however, be embodied in many different forms and should not be construed as limited to the embodiments set forth herein.
Example 1: Production of distilled water complex extract of Porphyra spp.
1 kg of mixed dry matter mixed with 2: 2: 1: 1 weight ratio of completely dried, spruce, spruce tree, gibberellike and quince tree was added to 9 liters of distilled water and extracted with hot water for 2 hours for 4 hours. The extract was filtered through 400 mesh filter cloth and concentrated under reduced pressure to obtain 31 g (dry weight).
Example 2: Manufacture of ethanol extract of phalaenopsis spp.
1 kg of a mixed sample, which is a mixture of completely dried, spruce, spruce, decoy, and quince tree at a weight ratio of 2: 2: 1: 1, is placed in 9 liters of ethanol and extracted with a condenser at 15 to 37 ° C for 14 days And repeated three times. The extract was filtered with a No. 2 filter paper of Watts. These plant extracts were concentrated under reduced pressure in a distillation apparatus equipped with a cooling condenser to obtain 35 g (dry weight).
Comparative Example 1: Manufacture of ethanol solely as an extract, in phalaenopsis, gibberellin, or quercetin
1 kg of each of the completely dried, entrained, spruce, goby, or quince tree was added to 9 L of ethanol and extracted in the same manner as in Example 2, followed by filtration and concentration under reduced pressure to obtain respective extracts.
Comparative Example 2: Preparation of Ethanol Composite Extract of Porphyra sp.
1 kg of a mixed sample obtained by mixing completely dried, entrained, and spruce wood at a weight ratio of 1: 1 was added to 9 liters of ethanol and extracted in the same manner as in Example 2, followed by filtration and concentration under reduced pressure to obtain a combined extract.
Comparative Example 3: Production of ethanol complex extracts of Pseudomonas sp.
1 kg of a mixed sample, which was a mixture of completely dried, chestnut tree, spruce tree, and goblin, at a weight ratio of 1: 1: 1, was added to 9 liters of ethanol and extracted in the same manner as in Example 2, followed by filtration and concentration under reduced pressure to obtain a combined extract.
Experimental Example One: Comparative Example 1 to 3, and Example 2 extracts DPPH Scatters Evaluation (antioxidant activity)
The dry extract of the spruce tree, the bark beetle or the quince tree, the dry extract of the spruce tree prepared in Comparative Example 2, and the ethanol extract of the spruce tree prepared in Comparative Example 1, The combined extracts of the ethanol extracts of the dry, participating, spruce, and omnivorous buds, and the dry, participating, spruce, gibberellate, and ginseng wood extracts prepared in Example 2 were suspended in methanol at a concentration of 100 μg / To form a sample solution, which was then diluted with DMSO.
DPPH reagent (1-diphenyl-2-picryl-hydrazyl) of 5 x 10 -4 M was mixed with 100 μl of each sample solution in a 96-well plate, stirred for 1 minute, reacted in an incubator at 25 ° C for 30 minutes And the absorbance was measured at 517 nm using a microplate counter. Vitamin C (100 μg / ml) was used as an experimental control, and the experiment was repeated four times.
The DPPH radical scavenging activity was evaluated by measuring the absorbance of the single extract of Comparative Example 1, the complex extract of Comparative Examples 2 and 3, the compound extract of Example 2 and the control (Control). The results are shown in Table 1 and FIG. 1 Respectively.
In order to evaluate DPPH radical scavenging ability, the sample composition of Blank, control, and experimental group (extract) used in the experiment is as follows.
Blank (2 wells): 100 [mu]
Control (2 wells): 100 μl of 100% MeOH, 100 μl of DPPH
Extract Sample: 2 μl of sample, 100 μl of 100% MeOH, 100 μl of DPPH
(1: 1)
(1: 1: 1)
(2: 2: 1: 1)
The antioxidant power of the extracts was calculated by the vitamin C standard curve and the IC 50 was calculated based on the dose response curve. The degree of extinction of the sample was expressed as ㎍ vitamin C equivalents per 100 mL (㎍ vitamin C equivalents per 100 mL) considering the correlation with the vitamin C standard curve.
As shown in Table 1, the IC 50 value of the compound extract of Example 2 was 11.4 占 퐂 / ml, which was significantly lower than that of the single extract of Comparative Example 1, the compound extract of Comparative Example 2, and the compound extract of Comparative Example 3 Respectively. This value was similar to that of positive control vitamin C, which is known to have a high antioxidant activity. Thus, the compound extract of Example 2 has the highest antioxidative activity.
1 is a graph showing DPPH free radical scavenging activity (%) according to the concentration of the complex extract prepared in Example 2 of the present invention. As shown in FIG. 2, the DPPH free radical scavenging ability was remarkably superior to vitamin C, which is a positive control group, at 100 占 퐂 / ml and 20 占 퐂 / ml of the combined extract of spruce, Respectively.
In addition, in the case of the extract obtained from the above-mentioned Comparative Example 1, the extract of Solanaceae, the spruce tree, the gibberellin, the extract of Prunus mume, the compound extract of Comparative Example 2 and the compound extract of Comparative Example 3, the concentration of the sample which scavenges the DPPH radical by 50% Was higher than that of the compound extract of Example 2, indicating that the compound extract of Example 2 had a higher antioxidant activity than the extract of Example 2.
Accordingly, the compound extract of the spruce tree, the spruce tree, and the spruce tree is considered to be the most effective means of the present invention. The extract of the spruce tree, the spruce tree, Compared with the complex extract of the ginseng extract, it has an excellent antioxidative activity by inhibiting free radical which accelerates the aging process of the skin. Therefore, it can exhibit the effect of lowering the aging process and skin damage by antioxidant activity.
Experimental Example 2: Comparative Example 1 to 3, and Example 2 inhibited tyrosinase activity (whitening effect)
The dry extract of the spruce tree, the bark beetle or the quince tree, the dry extract of the spruce tree prepared in Comparative Example 2, and the ethanol extract of the spruce tree prepared in Comparative Example 1, The combined extracts of P. aeruginosa, P. japonicus, P. japonicus, and P. japonica, which were prepared in Example 2, were assayed for tyrosinase activity.
Tyrosinase, an enzyme purified from potato or mushroom, was obtained from Sigma extracted from mushrooms. First, tyrosine, a substrate, was dissolved in a sodium phosphate buffer solution (0.1 M, pH 6.8) to prepare a solution having a concentration of 0.3 mg / ml. Then, 334 μl of the solution was taken into a test tube and then sodium phosphate buffer solution 0.1M, pH 6.8). The dried extracts of Comparative Examples 1 to 3 and Example 2 were dissolved in methanol to a concentration of 100 mg / ml, diluted with DMSO, and used as an experimental group. Each 2 μl of the diluted extract samples was added to the solution in the test tube and reacted in a 37 ° C thermostat for 10 minutes.
To evaluate tyrosinase activity of the sample, 1M Phosphate Buffer (PB) pH 6.8 was sterilized at 121 ° C for 20 minutes and cooled at room temperature (25 ° C). 1M Phosphate Buffer (PB) pH 6.8 was prepared at 1/15 M (final concentration = 66.6 mM) and L-DOPA was dissolved in phosphate buffer (pH 6.8) to a concentration of 2.0 mM. Tyrosinase was also dissolved in phosphate buffer (pH 6.8), and the concentration was adjusted to 46 units / ml.
In order to evaluate the tyrosinase activity, the sample compositions of the blank used in the experiment, the control, the single extract of Comparative Example 1, the combined extract of Comparative Examples 2 and 3, and the combined extract of Example 2 were as follows.
Blank (2 wells): 100 μl DMSO 2 μl, PB 160 μl, not treated
Control (2 wells): 2 μl of 100% DMSO, 120 μl of PB, 40 μl of Tyrosinase
Extract Sample: 2 ㎕ of sample, 120 ㎕ of PB, 40 ㎕ of tyrosinase
2 ㎕ of DMSO, 120 ㎕ of PB and 40 ㎕ of Tyrosinase were treated with 2 ㎕ of DMSO, 2 ㎕ of DMSO, 120 ㎕ of PB, and 120 ㎕ of PB, Tyrosinase And 40 μl of L-DOPA solution (2 mM) were added to each well. After incubation at 37 ° C for 10 min, OD (absorbance) was measured at 475 nm using a microplate counter. For arbutin used as a positive control, arbutin was dissolved in DMSO to a concentration of 100 mg / ml, and then diluted with DMSO to 100 μg / ml.
Tyrosinase activity was calculated using the following equation (1), and the results are shown in Table 2 and FIG.
Inhibition (%) = 1- (ControlO.D-SampleO.D) / (ControlO.D-BlankO.D) * 100 (%)
(1: 1)
(1: 1: 1)
(2: 2: 1: 1)
As shown in the above Table 2, compared with the single extract of Comparative Example 1, the compound extract of Comparative Example 2, and the compound extract of Comparative Example 3, the combined extract of Example 2, sprout, The IC 50 The amount of tyrosinase was significantly lower than that of arbutin, and the ability to inhibit the activity of tyrosinase was 5 times higher than that of arbutin.
Fig. 2 is a graph showing the tyrosinase activity (%) of the complex extract of the present invention. As shown in FIG. 2, tyrosinase activity was significantly lower in the positive control group than in the arbutin at the concentrations of 100 μg / ml and 20 μg / ml in the extracts of P. japonica, P. sp. In particular, at a concentration of 20 μg / ml of the complex extract, tyrosinase activity was markedly lower than 100 μg / ml of arbutin, indicating that the efficiency of inhibiting tyrosinase activity was remarkably high.
On the other hand, in the case of the extract alone, the concentration of the sample inhibiting 50% inhibition of tyrosinase activity was 12.25 / / ml, unlike the extracts of spruce, 2 complex extracts. However, in the case of the extract alone, the DPPH radical scavenging ability was low as shown in Experimental Example 1, and thus it was impossible to apply the extract to antioxidant use. On the contrary, with the participation of the present invention, the combined extracts of spruce, decanter, and quercetin have not only antioxidative activity but also excellent whitening activity, so that they can be applied simultaneously for antioxidative and whitening purposes.
As a result of the present invention, the combined extracts of the spruce tree, the spruce tree, and the spruce tree were found to be the extracts of the spruce tree, the spruce tree, the extract of the spruce tree, the combined extract of the spruce tree and the spruce tree, Compared with the complex extract, the tyrosinase activity, which plays a key role in the melanin biosynthesis process, is suppressed to a remarkably high level, and the production of melanin pigment is effectively inhibited, thereby preventing skin aging and whitening effect. In addition, as described above, it has an excellent antioxidative effect.
While the present invention has been particularly shown and described with reference to exemplary embodiments thereof, it is to be understood that the invention is not limited to the disclosed exemplary embodiments, Of the right.
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020160016208A KR101828584B1 (en) | 2016-02-12 | 2016-02-12 | Composition containing complex extracts including Veratrum nigrum var. ussuriense, Juglans mandshurica, Rodgersia podophylla and Chaenomeles sinensis with antioxidant activity or whitening |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020160016208A KR101828584B1 (en) | 2016-02-12 | 2016-02-12 | Composition containing complex extracts including Veratrum nigrum var. ussuriense, Juglans mandshurica, Rodgersia podophylla and Chaenomeles sinensis with antioxidant activity or whitening |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20170094903A true KR20170094903A (en) | 2017-08-22 |
KR101828584B1 KR101828584B1 (en) | 2018-03-29 |
Family
ID=59757913
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020160016208A KR101828584B1 (en) | 2016-02-12 | 2016-02-12 | Composition containing complex extracts including Veratrum nigrum var. ussuriense, Juglans mandshurica, Rodgersia podophylla and Chaenomeles sinensis with antioxidant activity or whitening |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101828584B1 (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2018169228A1 (en) * | 2017-03-15 | 2018-09-20 | 연세대학교 산학협력단 | Composition for preventing or treating pigmentation disorders caused by hyperpigmentation |
KR20200113583A (en) * | 2019-03-26 | 2020-10-07 | 안동대학교 산학협력단 | Pharmaceutical composition comprising the extract of rodgersia podophylla as an effective component for prevention or treatment of thrombosis and health functional food comprising the same |
KR20200113587A (en) * | 2019-03-26 | 2020-10-07 | 안동대학교 산학협력단 | Antimicrobial composition comprising the extract of rodgersia podophylla |
KR20200113586A (en) * | 2019-03-26 | 2020-10-07 | 안동대학교 산학협력단 | Pharmaceutical composition comprising the extract of rodgersia podophylla as an effective component for prevention or treatment of diabetes and health functional food comprising the same |
KR20210073089A (en) * | 2019-12-10 | 2021-06-18 | 재단법인 경기도경제과학진흥원 | Composition for Skin-lightening and Improving Wrinkle Using an Extract of Veratrum oxysepalum |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20200129794A (en) | 2019-05-10 | 2020-11-18 | 안동대학교 산학협력단 | Pharmaceutical composition comprising the extract of sageretia thea as an effective component for prevention or treatment of diabetes and health functional food comprising the same |
KR102254424B1 (en) | 2019-05-10 | 2021-05-20 | 안동대학교 산학협력단 | Antimicrobial composition comprising the extract of sageretia thea |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100757130B1 (en) * | 2001-07-11 | 2007-09-10 | 주식회사 엘지생활건강 | Cosmetic for skin whitening containing verazine and epi-verazine with inhibitory activity of melanin formation |
KR101292837B1 (en) * | 2011-10-20 | 2013-08-05 | 경희대학교 산학협력단 | Composition for skin wrinkle improvement comprising extracts of Junglans mandshurica MAXIM as an active ingredient |
-
2016
- 2016-02-12 KR KR1020160016208A patent/KR101828584B1/en active IP Right Grant
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2018169228A1 (en) * | 2017-03-15 | 2018-09-20 | 연세대학교 산학협력단 | Composition for preventing or treating pigmentation disorders caused by hyperpigmentation |
KR20200113583A (en) * | 2019-03-26 | 2020-10-07 | 안동대학교 산학협력단 | Pharmaceutical composition comprising the extract of rodgersia podophylla as an effective component for prevention or treatment of thrombosis and health functional food comprising the same |
KR20200113587A (en) * | 2019-03-26 | 2020-10-07 | 안동대학교 산학협력단 | Antimicrobial composition comprising the extract of rodgersia podophylla |
KR20200113586A (en) * | 2019-03-26 | 2020-10-07 | 안동대학교 산학협력단 | Pharmaceutical composition comprising the extract of rodgersia podophylla as an effective component for prevention or treatment of diabetes and health functional food comprising the same |
KR20210073089A (en) * | 2019-12-10 | 2021-06-18 | 재단법인 경기도경제과학진흥원 | Composition for Skin-lightening and Improving Wrinkle Using an Extract of Veratrum oxysepalum |
Also Published As
Publication number | Publication date |
---|---|
KR101828584B1 (en) | 2018-03-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101828584B1 (en) | Composition containing complex extracts including Veratrum nigrum var. ussuriense, Juglans mandshurica, Rodgersia podophylla and Chaenomeles sinensis with antioxidant activity or whitening | |
KR101997893B1 (en) | Method of increase the bioactive effectiveness of sprout ginseng | |
KR101393007B1 (en) | Cosmetic Composition for Skin-aging Protection and Wrinkle Improvement Comprising the Extract of Nephelium lappaceum and Litchi chinensis sonn as Active Ingredient | |
KR101677466B1 (en) | Anti-wrinkle Cosmetic Composition Comprising Hylocereus undatus (Haw.) Britt. and Rose Extract | |
KR20150064314A (en) | Cosmetic Composition Comprising Mangifera indica L. Extract, Passiflora edulis Sims Extract, Hylocereus undatus (Haw.) Britt. and Rose Extract, Actinidia chinensis Planch. Extract and Annona Squamosa Extract | |
WO2019124862A1 (en) | Skin wrinkle prevention and improvement composition containing schisandra chinensis extract as active ingredient | |
KR20170076972A (en) | COMPOSITION OF SKIN WHITENING CONTAINING EXTRACT OF Gloiopeltis Furcata AND METHOD OF MAKING THE SAME | |
KR102077069B1 (en) | Composition for anti-oxidation, skin whitening comprising Spartina alterniflora extracts as an active ingredient | |
KR101862093B1 (en) | Composition for antioxidant and whitening effects comprising extract of Tilia taquetii, Picrasma quassioides, Quercus mongolica, Geranium nepalense subsp. thunbergii | |
KR101420211B1 (en) | Skin Composition for External Application Using Bud and Sprout Extract | |
KR101863117B1 (en) | Composition comprising Androsace umbellate extract, Vaccinium oldhami extract, and Deutzia crenata extract | |
KR102619110B1 (en) | Antioxidant, skin whitening and skin wrinkle improvement composition | |
KR101960571B1 (en) | Method for preparing apricot extract, the apricot extract prepared therefrom, and skin care or cosmetic composition comprising the apricot extract | |
KR102154139B1 (en) | Composition comprising fermentation of sap of painted maple, cacao nibs extract and granat extract | |
KR101889492B1 (en) | composition containing complex extract of Morus alba for pendula, Prunus salicina and Oenothera lamarckiana | |
KR101888133B1 (en) | Composition For Promoting Synthesis of Collagen and Cosmetic Composition Using Extracts of Roots of Chrysanthemum indicum | |
KR20170111769A (en) | Composition containing complex extracts including Tuber magnatum mycelium, Morus bombycis, Agastache rugosa, Rubus hirsutus, and Zizyphus jujube with whitening or antioxidant activity | |
KR102527379B1 (en) | Chlorogenic acid enhanced Molochia extract and uses thereof | |
KR102313083B1 (en) | An anti-oxidative composition comprising an extract of Hydrangea petiolaris or a fraction thereof as an active ingredient | |
KR102619171B1 (en) | Composition for skin whitening comprising camellia extract | |
KR102214621B1 (en) | Functional food composition containing black kelp | |
KR101973860B1 (en) | Method for producing buckwheat sprout with increased rutin contents | |
KR20170137432A (en) | Composition for improving skin condition comprising herb extracts mixture | |
KR20170091238A (en) | Composition containing complex extracts including Acer saccharum Acerpseudo sibolianum and Acer ginnala with antioxidant activity | |
KR20170137498A (en) | Composition for improving skin condition comprising herb extracts mixture |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant |